.jpg)
FSNN, Jack Rosen and Huge Healthcare contracts. Here is the link that shows why Jack Rosen joined, and what the upside is. I highlighted the salient points, remember that FSNN provides VOIP and IP services, so users which means revenues.
Three Major HMOs Renew Contracts With Infu-Tech; Renewals Support Smartmeds.com Initiative
CARLSTADT, N.J., Jan. 20 /PRNewswire/ -- Infu-Tech, Inc. (Nasdaq: INFU), a
leading provider of specialty pharmaceuticals, announced today that it has
renewed contracts to provide infusion therapy and specialty pharmaceuticals to
Independence Blue Cross of Pennsylvania, Keystone Health Plans East of
Pennsylvania and Amerihealth of Pennsylvania and New Jersey. These HMOs
represent 1.5 million enrollees. In aggregate, Infu-Tech's managed care
network includes in excess of 70 HMO's with 25 million enrollees.
"The smartmeds.com initiative is enhanced by managed care contracts like
the ones announced today, as they are a critical referral source for us in the
expansion of our disease state management customer base," said Jack Rosen,
chairman of Infu-Tech. "Renewal of these contracts by these major HMOs is a
reflection of the excellent healthcare services that Infu-Tech has provided
them and other managed care entities."
"Continuation and expansion of such managed care customer relationships
are important to Infu-Tech as we create a platform for patients, physicians
and third party payors to communicate with each other online via Infu-Tech's
'Smartmeds.com' website," said Mr. Rosen. "And they are a key component in
making both our business-to-business and customer strategy successful."
Infu-Tech is a leading provider of high-quality, cost-efficient specialty
pharmaceutical and medical services to patients in their homes, ambulatory
infusion sites and in long-term care facilities. With more than 15 years of
clinical experience and managed care relationships with enrollees of more than
70 HMOs, large employer groups, Medicare and Medicaid, Infu-Tech has earned a
reputation for patient satisfaction and clinically proven success in
delivering high levels of service to special need patients.
The Smartmeds.com site will be supported by an advertising campaign on
"Infospace.com - Nasdaq: INSP". The initial website, which will include an
online pharmacy and interaction with medical professionals, will offer the
convenience and consistency of ordering specialty medications and other
medical products with a simple mouse click. Infu-Tech is accredited by the
Joint Commission on Accreditation of Health Care Organizations (JCAHO), and
the company's products and services are marketed in 27 states. Infu-Tech is a
publicly traded company, Nasdaq Smallcap: INFU.
Certain statements contained in this release are forward-looking.
Although Infu-Tech, Inc. believes that its expectations are based on
reasonable assumptions within the bounds of its knowledge of its business and
operations, there can be now assurance that actual results will not differ
materially from its expectations. Factors that could cause actual results to
differ from expectations include the difficulty in controlling healthcare
costs, integrating new operations from acquired companies and the possible
negative effects of prospective healthcare reforms. For other important
factors that may cause actual results to differ materially from expectations
and underlying assumptions, see reports by Infu-Tech, Inc. filed with the
Securities and Exchange Commission.
